Strs Ohio Invitae Corp Transaction History

Strs Ohio

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$0.6 - $1.53 $109,080 - $278,154	181,800 Added 46.86%	569,800 $341,000
Q2 2023 Jul 31, 2023	BUY	$1.05 - $1.63 $81,165 - $125,998	77,300 Added 24.88%	388,000 $438,000
Q1 2023 Aug 02, 2023	SELL	$1.2 - $2.73 $92,760 - $211,029	-77,300 Reduced 19.92%	310,700 $419,000
Q1 2023 Apr 27, 2023	BUY	$1.2 - $2.73 $103,800 - $236,145	86,500 Added 38.58%	310,700 $419,000
Q3 2022 Oct 27, 2022	SELL	$1.9 - $8.63 $80,750 - $366,775	-42,500 Reduced 15.94%	224,200 $551,000

Q2 2022 Jul 25, 2022	BUY	$2.13 - $9.01 $558,486 - $2.36 Million	262,200 Added 5826.67%	266,700 $650,000
Q4 2021 Jan 24, 2022	SELL	$14.7 - $28.67 $277,830 - $541,863	-18,900 Reduced 80.77%	4,500 $68,000
Q3 2021 Oct 22, 2021	SELL	$24.31 - $33.6 $48,620 - $67,200	-2,000 Reduced 7.87%	23,400 $665,000
Q2 2021 Jul 26, 2021	BUY	$26.09 - $40.4 $96,533 - $149,480	3,700 Added 17.05%	25,400 $856,000
Q1 2021 Apr 23, 2021	BUY	$33.06 - $56.93 $62,814 - $108,167	1,900 Added 9.6%	21,700 $829,000
Q4 2020 Jan 25, 2021	BUY	$39.09 - $57.4 $27,363 - $40,180	700 Added 3.66%	19,800 $827,000
Q3 2020 Dec 14, 2020	BUY	$28.43 - $44.67 $133,621 - $209,949	4,700 Added 32.64%	19,100 $827,000
Q2 2020 Jul 23, 2020	BUY	$11.71 - $30.29 $168,624 - $436,176	14,400 New	14,400 $436,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.